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High-level immune activation and T cell apopto-
sis represent a hallmark of HIV-1 infection that
is absent from nonpathogenic SIV infections in
natural primate hosts. Themechanisms causing
these varying levels of immune activation are
not understood. Here, we report that nef alleles
from the great majority of primate lentiviruses,
including HIV-2, downmodulate TCR-CD3 from
infected T cells, thereby blocking their respon-
siveness to activation. In contrast, nef alleles
from HIV-1 and a subset of closely related SIVs
fail to downregulate TCR-CD3 and to inhibit
cell death. Thus, Nef-mediated suppression of
T cell activation is a fundamental property of
primate lentiviruses that likely evolved to main-
tain viral persistence in the context of an intact
host immune system. This function was lost
during viral evolution in a lineage that gave rise
to HIV-1 and may have predisposed the simian
precursor of HIV-1 for greater pathogenicity in
humans.
INTRODUCTION
Progression to AIDS in HIV-1-infected humans is charac-
terized by high levels of immune activation associated
with accelerated T cell turnover rates and apoptotic death
(reviewed in Stevenson, 2003). In contrast, markedly lower
levels of T cell activation, proliferation, and apoptosis arefound in naturally SIV-infected primates, e.g., sooty man-
gabeys and African green monkeys, which do not develop
immunodeficiency despite high systemic viral loads (re-
viewed in Hirsch, 2004; Silvestri, 2005). Consistent with
a deleterious role in primate lentiviral infection, T cell acti-
vation is the strongest predictor of progression to AIDS in
HIV-1-infected humans (Giorgi et al., 1999; Sousa et al.,
2002) and the only consistent difference between patho-
genic and nonpathogenic HIV/SIV infections (reviewed
in Silvestri, 2005); however, the mechanisms responsible
for the observed differences in infection-associated acti-
vation levels remain unknown.
One viral gene product that has been implicated in im-
mune activation and viral pathogenicity is the accessory
protein Nef (reviewed in Renkema and Saksela, 2000; Wei
et al., 2003). Humans infected with nef-defective HIV-1
exhibit a slow/nonprogressor phenotype (Deacon et al.,
1995; Kirchhoff et al., 1995), and macaques inoculated
with nef-deleted SIVmac have extremely low viral loads,
resulting in either no pathogenicity or a markedly pro-
tracted disease course (Kestler et al., 1991). Several Nef
functions have been identified that may contribute to this
phenotype, such as its ability to downregulate CD4,
CD28, and class I MHC (MHC-I) (reviewed in Wei et al.,
2003), which is believed to facilitate virus immune evasion
(reviewed in Johnson and Desrosiers, 2002; Skowronski
et al., 1999). HIV-1 Nef has also been reported to directly en-
hance the responsiveness of T cells to activation (Fenard
et al., 2005; Fortin et al., 2004; Wang et al., 2000), but this
effect was not uniformly observed among primate lentivi-
ruses (Bell et al., 1998; Howe et al., 1998; Mu¨nch et al.,
2005). Taken together, Nef has been characterized as a po-
tent, multifunctional virulence factor of primate lentiviruses.Cell 125, 1055–1067, June 16, 2006 ª2006 Elsevier Inc. 1055
SIVs infect a wide variety of nonhuman primate species
in sub-Saharan Africa (reviewed in Hahn et al., 2000;
Sharp et al., 2005). In contrast to HIV-1 and HIV-2 infec-
tions of humans, natural SIV infections are usually not
pathogenic for their primary hosts (reviewed in Hirsch,
2004; Silvestri, 2005). Currently, over 30 different SIVs
have been molecularly characterized. Although all of
them encode a nef gene (Leitner et al., 2005), functional
data are almost exclusively derived from the HIV-1 Nef
protein. To examine the function of Nef from an evolution-
ary perspective, we report here a comprehensive analysis
of nef alleles from a variety of divergent SIV lineages. Us-
ing an experimental system allowing us to investigate Nef
function in the context of replicating virus, we found that
all primate lentiviral Nefs downmodulate CD4, CD28,
and MHC-I. However, the ability to modulate the surface
expression of the T cell receptor (TCR) complex differed
markedly depending on the particular lentiviral lineage
analyzed. Nef proteins from the great majority of primate
lentiviruses efficiently downmodulated TCR-CD3, thereby
suppressing the responsiveness of infected T cells to ac-
tivation and activation-induced cell death (AICD). By con-
trast, the Nef proteins of HIV-1 and its closest simian rela-
tives failed to downmodulate TCR-CD3 and to prevent
AICD. Our data thus show that Nef exerts an important
protective function that was lost during lentiviral evolution
in a lineage that gave rise to HIV-1. We posit that this Nef
activity is needed to prevent the chronic generalized T cell
activation typical of pathogenic HIV infection and thus
contributes to the nonpathogenic phenotype of natural
SIV infections.
RESULTS
The Great Majority of Primate Lentiviral Nef Proteins
Downmodulate TCR-CD3
Nef alleles (n = 30) from different primate lentiviruses (see
Table S1 in the Supplemental Data available with this arti-
cle online) were cloned into a replication-competent HIV-1
(NL4-3-based) proviral vector designed to coexpress Nef
and eGFP from a bicistronic RNA (Schindler et al., 2003).
In these constructs, nef expression is mediated by the
wild-type HIV-1 LTR promoter and naturally occurring
splice sites; however, cells infected with these reporter
viruses coexpress Nef and eGFP at correlating levels
(Schindler et al., 2005). Thus, in this system, the effect of
Nef on the surface expression of cellular receptors can
be examined directly in virally infected cells. Figure 1
shows such an analysis for CD4, MHC-1, CD3, and
CD28 molecules on Jurkat T cells transduced with viral
constructs expressing highly divergent HIV/SIV nef genes
(as well as a nef-minus control). All nef-containing viruses
downregulated CD4 and MHC-I, indicating that they ex-
pressed biologically active Nef proteins. However, the
effect on TCR-CD3 surface expression was highly vari-
able. The majority of viral nef constructs, including those
of SIVsmm, SIVmac, and HIV-2 but also those of SIVrcm,
SIVdeb, SIVsyk, SIVblu, SIVsun, SIVtan, and SIVsab,1056 Cell 125, 1055–1067, June 16, 2006 ª2006 Elsevier Inc.downmodulated TCR-CD3 efficiently; however, no such
effect was observed for nef alleles of HIV-1, SIVcpz,
SIVgsn, SIVmus, and SIVmon (Figure 1; Table S1).
To quantify the extent of receptor downmodulation, the
mean fluorescence intensity (MFI) of cells infected with
nef-defective virus (e.g., 48.7 for CD4) was divided by the
MFI of cells infected with constructs coexpressing Nef
and eGFP (e.g., 7.4 for NL4-3 Nef-mediated downregula-
tion of CD4; Figure 1A). Results were tabulated separately
for viral constructs that failed (group 1; n = 12) versus those
that were capable of TCR-CD3 downmodulation (group 2;
n = 18). For clarity, both groups were further subdivided
to distinguish Nef proteins from the two human AIDS vi-
ruses and their immediate SIV counterparts (HIV-1/CPZ
and HIV-2/SMM/MAC) from those of the remaining SIVs
(GSN/MUS/MON and all other SIVs). The extent of TCR-
CD3 downmodulation of group 2 nef alleles ranged from
5.7- to 18.0-fold, whereas group 1 Nefs completely failed
to diminish TCR-CD3 surface expression (Figure 1B).
Many group 2 nef alleles were also highly active in downre-
gulating CD28, an important costimulatory molecule of T
cell activation (reviewed in Riley and June, 2005), but this
phenotype was more variable. The functional differences
between the two groups were statistically highly significant
(p < 0.004 for both CD28 and TCR-CD3 downmodulation)
and were not biased by different transduction efficiencies
because CD4, MHC-I, TCR-CD3, and CD28 expression
levels were all measured simultaneously in the same
cultures.
Nef-Mediated TCR-CD3 Downmodulation Blocks
Activation of Virally Infected T Cells
HIV-1 Nef is known to enhance the responsiveness of T
cells to activation (Fenard et al., 2005; Fortin et al., 2004;
Wang et al., 2000). Since most primate lentiviral Nefs
tested downmodulated TCR-CD3 and CD28 (Table S1),
we hypothesized that they might inhibit, rather than en-
hance, T cell activation. Nuclear factor of activated T cells
(NFAT) represents an important regulator of IL-2 gene ex-
pression, one of the hallmarks of T cell activation. We thus
infected Jurkat T cells stably transduced with an NFAT-
dependent luciferase gene (Fortin et al., 2004) with the
HIV-1 Nef/eGFP constructs and determined their respon-
siveness to activation. Compared to uninfected control
cultures, T cells infected with nef-defective HIV-1 ex-
hibited an average of 4.6-fold increase of NFAT activity af-
ter stimulation with phytohemagglutinin (PHA) (Figure 2A).
This increase in NFAT activation was even greater in cells
expressing HIV-1/CPZ (7.7 ± 1.2, n = 9) and GSN/MUS/
MON nef alleles (5.8 ± 0.7, n = 3; numbers indicate aver-
age values ± SD). However, virtually no NFAT activity
was detected in cell cultures expressing HIV-2/SMM/
MAC (0.7 ± 0.1, n = 8) or other SIV nef alleles (0.6 ± 0.1,
n = 10). Remarkably, in these latter cases, NFAT activities
were lower than those detected in uninfected cells, indi-
cating active suppression of early T cell activation by
these nef alleles. Similar results were observed for a sec-
ond activation marker, CD69, which was only induced in
Figure 1. Differential Regulation of Surface-Receptor Expression by Primate Lentiviral Nef Proteins
(A) Flow cytometric analysis of CD4, MHC-I, CD3, and CD28 expression in Jurkat cells infected with HIV-1 recombinants expressing eGFP alone
(nef) or together with nef alleles derived from the primate lentiviruses indicated. eGFP expression levels used to calculate receptor downmodulation
and the MFIs are indicated.
(B) Quantitative assessment of Nef-mediated downmodulation of the indicated cellular receptors. Each symbol represents n-fold downmodulation of
the indicated receptor molecule by one of the 30 individual nef alleles analyzed. Group 1 and 2 nef alleles are color coded red and green, respectively.
Open symbols indicate values obtained for Nef proteins of human viruses (HIV-1 and HIV-2).cells expressing group 1 nef alleles (Figure S1A). Notably,
Jurkat cells infected with group 1 and group 2 HIV-1 Nef/
eGFP constructs responded equally well to stimulation
with PMA/ionomycin, which bypasses surface receptors
and directly activates intracellular signaling pathways
(data not shown).
To mimic stimulation by APCs, we next examined the
effect of the different nef alleles on the activation status
of infected Jurkat T cells treated with anti-CD3/CD28
beads which crosslink the TCR with CD28 (Trickett and
Kwan, 2003). Again, HIV-1/CPZ and GSN/MUS/MON nef
alleles enhanced and the remaining nef alleles inhibited
T cell activation (Figure 2B), and these results correlated
with NFAT induction data obtained following PHA stimula-tion (Figure S1B). Thus, various stimuli, including PHA, anti-
CD3/CD28 beads, and anti-CD3 antibody (data not shown),
all yielded the same results: nef genes derived from HIV-1
and a subset of closely related simian relatives caused
hyper-responsiveness of virally infected T cells, whereas
the nef alleles of HIV-2 and all other SIVs inhibited T cell
activation.
Nef-Mediated TCR-CD3 Downmodulation Protects
Infected PBMCs against AICD
In acute primate lentiviral infection, the primary target cells
are memory CD4+CCR5+ T cells that are phenotypically
resting but are believed to represent a recently activated
cell population (Li et al., 2005; Mattapallil et al., 2005).Cell 125, 1055–1067, June 16, 2006 ª2006 Elsevier Inc. 1057
Figure 2. Nef-Mediated Differences in Responsiveness to T Cell Stimulation
Jurkat cells stably transfected with an NFAT-dependent reporter gene were transduced with HIV-1 Nef/eGFP constructs expressing either no nef
(nef/*) or nef alleles derived from the various groups of primate lentiviruses. Cultures were stimulated with PHA (A) or anti-CD3/CD28 beads (B).
The left panels indicate NFAT-dependent luciferase reporter activities in Jurkat T cells infected with the respective HIV-1 Nef variants relative to those
measured in uninfected cells. The average levels of NFAT induction measured in uninfected cells and in nef-defective HIV-1 infection are indicated by
solid and broken lines, respectively. The right panels show that inhibition of NFAT induction correlates with Nef-mediated downmodulation of TCR-
CD3. Group 1 and 2 nef alleles are color coded as in Figure 1.To mimic this phenotype in vitro, we transduced PHA-
stimulated peripheral blood mononuclear cells (PBMCs)
with the HIV-1 Nef/eGFP constructs and incubated them
in the absence of exogenous stimuli until they expressed
low levels of activation markers and resembled resting
cells (Figure 3A). Thereafter, the cells were exposed to a
second PHA stimulus and examined for the expression
of activation markers and signs of apoptosis. Flow cyto-
metric analysis showed that all nef alleles that downmodu-
lated CD28 and TCR-CD3 on Jurkat T cells also did so
on human PBMCs (Figures S1C and S1D). Interestingly,
downmodulation of TCR-CD3 in infected primary cells re-
quired much lower levels of nef expression than downre-
gulation of CD28 (Figure 2B). Induction of CD69 as an early
marker, and the IL-2 receptor (IL-2R) as a late marker, for T
cell activation was enhanced by group 1 Nefs but inhibited
by all other Nef proteins. Most importantly, PHA-treated
PBMC cultures infected with HIV-1 constructs expressing
group 1 Nefs exhibited substantially higher levels of AICD
compared to those expressing group 2 Nef proteins. For
example, the frequency of annexin V+ apoptotic cells in-
fected with the HIV-1 NA7 Nef construct increased from
8.5% to 33.9% over a period of 2 days, while only about
10% of cells expressing HIV-2, SIVmac, or SIVsab Nefs
became apoptotic in this same time period (Figure 3C).
Quantitative assessment of the effects of all 30 nef al-
leles demonstrated that PBMCs infected with viruses con-
taining group 1 Nefs expressed about 4-fold higher levels
of CD69 (Figure 3D) and 2-fold higher levels of IL-2R
(Figure 3E) compared to cells expressing group 2 Nefs
(p < 0.0001 in each case). CD69 and IL-2R expression
levels in these cultures correlated significantly (Fig-1058 Cell 125, 1055–1067, June 16, 2006 ª2006 Elsevier Inc.ure S1E). Moreover, group 2 Nefs (14.2% ± 0.9%) pre-
vented AICD much more efficiently than group 1 Nefs
(28.0% ± 1.7%; p < 0.0001; numbers indicate mean per-
centages ± SEM of apoptotic cells) (Figure 3F). Again,
the ability of Nef to inhibit the induction of CD69, IL-2R,
and apoptosis was dependent on TCR-CD3 downmodu-
lation (Figures 3D–3F, right panels), and a higher state of
activation correlated with enhanced apoptosis (Fig-
ure S1F). In contrast to PHA activation, treatment with
an anti-Fas antibody (CD95 mAb) resulted in virtually iden-
tical levels of programmed death in PBMCs infected with
group 1 and group 2 Nef-containing HIV-1 (Figure S2). This
result shows that cells infected with viruses expressing
group 1 Nef exhibit higher levels of TCR-CD3-mediated,
but not FAS-mediated, activation-induced apoptosis. In-
terestingly, the caspase inhibitor zVAD-FMK abolished
the higher levels of apoptosis in PHA-activated PBMC
cultures expressing group 1 Nefs, pointing to enhanced
caspase activity as a potential underlying mechanism
(Figure S2).
To demonstrate a causal relationship between Nef-in-
duced TCR-CD3 downmodulation and reduction of T
cell activation and apoptosis, we generated nef mutants
that were selectively active or defective in this function.
A truncated form of the SIVmac239 nef gene (tNef) effi-
ciently downmodulated TCR-CD3 but was defective in
other Nef functions (Figure 4A, column 6) (Mu¨nch et al.,
2002). Conversely, deletion of amino acids 23–30 in the
SIVdeb nef gene (D23–30) specifically abrogated this pro-
tein’s ability to downmodulate TCR-CD3 but did not dis-
rupt its other activities (Figure 4A, column 8). Functional
analysis demonstrated that the SIVmac tNef, but not the
SIVdeb D23–30 Nef, blocked the induction of NFAT and
upregulation of CD69 in HIV-1-infected Jurkat T cells (Fig-
ures 4B and 4C). Moreover, the SIVmac tNef, but not
the SIVdeb D23–30 Nef, inhibited activation and AICD of
HIV-1-infected primary PBMCs (Figures 4D–4F). Thus,
Nef-mediated TCR-CD3 downmodulation is required
and sufficient to inhibit T cell activation and AICD.
Nef-Mediated TCR-CD3 Downmodulation Inhibits
Activation of Sooty Mangabey T Cells
To assess whether Nef function was dependent on the
proviral context or the species origin of the target cell,
we used HIV-1, SIVmac, and SIVagm Nef/eGFP con-
structs to transduce primary PBMCs from sooty manga-
beys (SMs), a natural host of SIVsmm (Silvestri, 2005).
As shown in Figure 5A, SIVmac and SIVagm Nefs, but
not the HIV-1 Nef, downmodulated TCR-CD3 and in-
hibited IL-2R activation in SM PBMCs (note that although
infected SM cells expressed overall reduced levels of
CD4, downmodulation was more efficient in the presence
of Nef). Remarkably, proviral constructs expressing differ-
ent nef alleles exhibited the same phenotype in human and
SM PBMCs (Figures 5B and 5C). For example, group 2
SIVsmm, SIVmac, and SIVdeb nef alleles as well as the
SIVmac tNef mutant all downmodulated TCR-CD3 and
inhibited activation of SM PBMCs (Figure 5C), and there
was an overall highly significant correlation between the
extent of Nef-mediated modulation of TCR-CD3, CD28,
and IL-2R surface expression in human- and SM-derived
PBMCs (Figures 5D–5F). Thus, the effect of Nef on T cell
activation is independent of the proviral context and is
conserved in target cells from divergent primate species.
Inefficient Nef-Mediated Downmodulation
of TCR-CD3 Is Associated with CD4+ T Cell Loss
in SIVsmm-Infected Sooty Mangabeys In Vivo
Although the great majority of SMs do not develop immu-
nodeficiency or CD4+ T cell depletion as a consequence of
SIVsmm infection (Silvestri, 2005), recent studies indicate
that approximately 10%–15% of animals experience con-
siderable CD4+ T cell loss (B. Sumpter, R. Dunham, S.
Gordon, J. Engram, M. Paiardini, M. Cervasi, H. McClure,
S. Staprans, D.L.S., and G.S., unpublished data). To ex-
amine whether this in vivo phenotype is associated with
differences in Nef function, we analyzed SIVsmm nef al-
leles from 8 SMs with low (<450/mm3) and 11 SMs with
normal CD4+ T cell counts (>450/mm3). Nef alleles were
amplified directly from the plasma of infected animals
and cloned into a vector coexpressing nef and GFP from
a bicistronic RNA (Greenberg et al., 1998). To ensure rep-
resentation of the nef quasispecies, all 19 amplicons were
cloned and tested in bulk (for quality control, two clones
per amplicon were also sequenced and phylogenetically
analyzed; Figure S3). These analyses revealed that nef
genes from SIVsmm-infected SMs with low CD4+ T cells
counts were significantly less active in downmodulating
TCR-CD3 than nef alleles from animals with normal
CD4+ counts, while these two groups of nef alleles didnot differ significantly in their ability to downmodulate
CD4 (Figure 6A). It should be noted that the nef allele
from a single SM with very low CD4+ T cell counts (3/
mm3) downregulated all four surface receptors only poorly
and may thus be generally functionally impaired. How-
ever, exclusion of this animal from the analyses did not
change the results: The difference in TCR-CD3 downmo-
dulation between ‘‘CD4 high’’ and ‘‘CD4 low’’ animals
remained statistically significant (p = 0.0056). A linear re-
gression analysis illustrating this correlation is shown in
Figure 6B. Finally, nef genes from SMs with low CD4+ T
cell counts were frequently also less active in downmodu-
lating MHC-I and CD28, but these differences were less
pronounced. In summary, Nef-mediated downmodulation
of TCR-CD3, and to a lesser extent of CD28 and MHC-I, is
associated with stable CD4+ T cell counts in SIVsmm-in-
fected SMs. Since in most of these animals there is also
a significant correlation between decreased CD4+ T cell
counts and increased immune activation (B. Sumpter, R.
Dunham, S. Gordon, J. Engram, M. Paiardini, M. Cervasi,
H. McClure, S. Staprans, D.L.S., and G.S., unpublished
data), these results suggest that Nef plays an important
protective role in maintaining low levels of T cell activation
in naturally infected primates in vivo.
DISCUSSION
Nef-Mediated TCR-CD3 Downmodulation Is Highly
Conserved throughout Primate Lentiviral Evolution
Previous studies of HIV-1 Nef have identified this acces-
sory protein as an enhancer of T cell activation (Fenard
et al., 2005; Fortin et al., 2004; Wang et al., 2000). In this
paper, we confirm this finding for all three groups of HIV-
1 (M, N, and O) but also show that the Nef proteins of
most other primate lentiviruses exhibit a remarkably differ-
ent phenotype. Essentially all SIV Nefs, except for a small
subset, downmodulate TCR-CD3, in addition to CD4 and
MHC-I. The exceptions include the chimpanzee precursor
of HIV-1, SIVcpz, as well as three Cercopithecus viruses,
SIVgsn, SIVmus, and SIVmon. The latter three form a tight
clade in phylogenetic trees (Figure 7A) and are closely re-
lated to SIVcpz (and HIV-1) in the env gene (Bailes et al.,
2003). However, in the nef gene (as well as gag and pol re-
gions), SIVcpz is most closely related to SIVrcm, reflecting
its recombinant ancestry (Bailes et al., 2003). Indeed, the
entire SIVcpz nef gene is SIVrcm derived, since the re-
combination event that generated SIVcpz also introduced
a duplication of the 30 terminus of env/50 terminus of nef,
thereby eliminating the nef/env overlap that is typical of
all other primate lentiviruses (Figure 7B). Since the SIVrcm
Nef protein downmodulates TCR-CD3 but the (SIVrcm-re-
lated) SIVcpz Nef protein does not (Table S1), this function
must have been lost twice during primate lentiviral evolu-
tion: once on the branch leading to the SIVgsn/mus/mon
clade, and a second time after the recombination event
that generated SIVcpz. In the context of primate lentivirus
evolution, these two events are comparatively recent,
whereas the Nef-mediated TCR-CD3 downmodulationCell 125, 1055–1067, June 16, 2006 ª2006 Elsevier Inc. 1059
Figure 3. Activation and AICD of Virally Infected PBMC Cultures
(A) Schematic representation of the experimental procedure. Human PBMCs were transduced with HIV-1 eGFP/Nef constructs 3 days after PHA
stimulation and cultured until they expressed low levels of CD69 and IL-2R, i.e., exhibited a resting phenotype. Thereafter, the PBMCs were exposed
to a second PHA stimulus and examined for the expression of T cell activation markers and apoptotic features.
(B) Flow cytometric analysis of CD3, CD28, and CD69 expression by PBMCs infected with HIV-1 constructs expressing the indicated nef alleles at
1 day poststimulation (dps) and of IL-2R expression at 4 dps. ‘‘Unst.’’ specifies control cells that did not receive the second PHA stimulus.
(C) Kinetics of apoptosis in a representative experiment. Percentages of annexin V+ apoptotic cells in uninfected cultures or in HIV-1-infected cells
expressing eGFP alone (nef) or together with the indicated nef alleles are indicated.1060 Cell 125, 1055–1067, June 16, 2006 ª2006 Elsevier Inc.
Figure 4. Modulation of Receptor Expression, T Cell Activation, and Apoptosis by Selective nef Mutants
(A) Flow cytometric analysis of Jurkat cells infected with HIV-1 constructs expressing eGFP alone (nef) or with the nef alleles indicated.
(B and C) Analysis of Jurkat cells stably transfected with an NFAT-dependent reporter gene following transduction with the indicated HIV-1 Nef/eGFP
constructs indicated. Levels of NFAT-dependent luciferase reporter activity (B) and CD69 expression (C) are the average (±SEM) of four experiments.
Mock specifies uninfected control cells. Nef alleles capable or defective of TCR-CD3 downmodulation are shown in green and red, respectively.
(D–F) Analysis of human PBMCs following transduction with the indicated HIV-1 IRES/eGFP constructs. CD69 (D) was measured 1 day following
a second PHA stimulus; IL-2R expression levels (E) and the frequencies of apoptotic cells (F) were measured 4 dps. Results are representative of
three to six experiments.function represents a characteristic feature of longstand-
ing virus/host relationships.
Nef-Mediated TCR-CD3 Downmodulation: A Key
Contributor to the Nonpathogenic Phenotype
of Natural SIV Infections?
CD4+ T cell activation requires the interaction of the TCR-
CD3 complex with the MHC class II complex presenting
antigen specific peptides as well as a CD28/B7-mediated
costimulation. Primate lentiviral Nefs that effectively block
T cell activation by downmodulating TCR-CD3 do so in
human as well as sooty mangabey PBMCs (Figure 5), indi-
cating that this function is independent of the species or-Cigin of the infected host cell. Moreover, SMs infected with
SIVsmm strains whose Nefs were capable of downmodu-
lating TCR-CD3 maintained normal CD4+ T cell counts,
while animals infected with SIVsmm strains whose Nefs
were less active in this function experienced progressive
CD4+ T cell loss (Figure 6; note that Nef-mediated TCR-
CD3 downmodulation is generally much more pro-
nounced in primary PBMCs than in immortalized T cells).
Since the latter animals also exhibited signs of increased
in vivo immune activation (B. Sumpter, R. Dunham, S. Gor-
don, J. Engram, M. Paiardini, M. Cervasi, H. McClure, S.
Staprans, D.L.S., and G.S., unpublished data), it is tempt-
ing to speculate that, in most natural SIV infections, there(D–F) CD69 (D) was measured 1 day after the second stimulus, and IL-2R expression levels (E) and the frequencies of apoptotic cells (F) were mea-
sured by FACS at 4 dps. The average levels of CD69, IL-2R, and apoptotic cells in uninfected or nef HIV-1 infected cells are indicated by solid or
broken lines, respectively. The right panels show that inhibition of CD69 and IL-2R induction and apoptosis correlate with Nef-mediated downmo-
dulation of TCR-CD3. Group 1 and 2 nef alleles are color coded as in Figure 1.ell 125, 1055–1067, June 16, 2006 ª2006 Elsevier Inc. 1061
Figure 5. Nef-Mediated Receptor Modulation in Primary Sooty Mangabey PBMC
(A) Surface expression of CD4, CD3, CD28, and IL-2R receptors on SM PBMCs infected with HIV-1, SIVmac, or SIVagm Nef/eGFP constructs con-
taining intact (+) or disrupted () nef genes. Receptor expression levels on uninfected cells were set to 100% in (A) and (C)–(F), and values in (A) and (C)
are means ±SEM derived from four or five transductions.
(B) Flow cytometric analysis of SM PBMCs infected with HIV-1 Nef/eGFP constructs expressing HIV-1, SIVsmm, SIVmac, and SIVdeb wild-type (NL4-
3, NA7, FFm1, 239, and CM40), mutant (tNef and D23–30), or no () nef genes. The range of eGFP expression used to calculate the percentages of
receptor expression and MFIs is indicated.
(C) Relative CD4, CD3, CD28, and IL-2R cell-surface expression levels on SM PBMCs infected with the indicated HIV-1 Nef/eGFP construct. Nef
alleles are color coded as in Figure 4.
(D and E) Nef-mediated modulation of TCR-CD3, CD28, and IL-2R in human and SM PBMCs. Open symbols indicate values obtained for the nef
control.is a direct link between Nef’s ability to downmodulate
TCR-CD3 and the maintenance of an intact immune
system.
In HIV-1-infected humans, most CD4+ T cell killing oc-
curs in the acute phase of infection when the majority of
mucosal CD4+ memory T cells are destroyed by direct,1062 Cell 125, 1055–1067, June 16, 2006 ª2006 Elsevier Inc.virally mediated mechanisms (Brenchley et al., 2004; Li
et al., 2005; Mattapallil et al., 2005; Mehandru et al.,
2004). It has been proposed that acute HIV-1 infection
should be viewed as a ‘‘selective memory T cell lympho-
penia’’ and that the high levels of immune activation ob-
served during chronic infection are secondary to this
Figure 6. Nef Protein Function in
SIVsmm-Infected SMs with and without
Progressive CD4+ T Cell Loss
(A) SIVsmm nef genes were grouped by CD4+ T
cell counts of the animals from which they were
derived. Values for downregulation of CD4,
CD3, CD28, and MHC-I at a medium range of
eGFP expression levels are indicated and are
representative of two experiments (p values
are shown).
(B) Correlation between Nef-mediated TCR-
CD3 downmodulation and CD4+ T cell counts.depletion, due to a breakdown of gut immune responses
and/or compensatory mechanisms aimed at replenishing
CD4+ T cells in lymphatic organs (Brenchley et al., 2006).
Interestingly, SIV infection of SMs is also associated with
substantial depletion of mucosal memory CD4+ T cells
(S. Gordon, J. Engram, J. Milush, R. Dunham, N. Klatt,
E. Strobert, I. Pandrea, S. Staprans, D.L.S., and G.S., un-
published data); however, in these infections, CD4+ T cell
loss is not followed by generalized immune hyperactiva-
tion. The reasons for this are not understood, but the re-
sults reported here strongly suggest a protective role ofthe SIV nef gene product. Nef-mediated downmodulation
of TCR-CD3 reduces T cell activation and activation-
induced cell death and may possibly also decrease by-
stander apoptosis through reduced expression of proa-
poptotic proteins or inflammatory cytokines. Moreover,
SIV Nef is likely to protect infected cells against killing by
cytotoxic T lymphocytes via MHC-I downregulation (Col-
lins et al., 1998). Finally, SIV Nef may further inhibit im-
mune activation and apoptosis by efficient downmodula-
tion of CD28 and possibly other functions, such as
inhibition of T cell trafficking (Hrecka et al., 2005). Thus,Figure 7. Evolutionary Relationship of Lentiviral Nef Proteins and Phylogenetic Evidence for a Sequence Duplication in the
Genomes of SIVcpz and HIV-1
(A) Phylogenetic analysis of Nef proteins listed in Table S1. Group 1 and 2 sequences are color coded as in Figure 1. The numbers on branches are
percentage posterior probabilities; only values of 95% and above are shown in (A), and only probabilities above 80% are shown in (B). The scale bars
indicate 0.2 substitutions per site.
(B) Duplication in the SIVcpz/HIV-1 lineage. The 30 end of env (magenta) and the 50 end of nef (blue) sequences from the indicated HIV-1 and SIVcpz
strains were aligned with the overlapping region of env and nef from various SIV and HIV-2 strains. Except for MVP5180 (L20571) and SIVcpzANT
(U42720), all GenBank accession numbers are listed in Table S1. The gap-stripped alignment was 135 nucleotides. The tree was made by the Bayes-
ian method using the general reversible (GTR) model of evolution, with g distributed rates at sites run for 10 million generations.Cell 125, 1055–1067, June 16, 2006 ª2006 Elsevier Inc. 1063
Nef-mediated reduction of T cell activation may represent
a key determinant in ensuring that natural SIV infections
are nonpathogenic in their natural hosts.
Vpu Appears to Diminish the Selective Advantage
of Nef-Mediated TCR-CD3 Downmodulation
If TCR-CD3 downmodulation serves to maintain virus rep-
lication and persistence in the context of an intact host
immune system, how do primate species cope with SIVs
that have lost this Nef function? While there is virtually
no information about the natural history of SIVgsn, SIV-
mus, and SIVmon infections in their primate hosts, there
is evidence that these viruses are much less prevalent
than ‘‘regular’’ SIV infections. For example, only 3% and
4% of mustached and greater spot-nosed monkeys are
infected with SIVmus and SIVgsn, respectively, compared
to 50% to 90% of wild-living SMs, African green monkeys,
and mandrills (Aghokeng et al., 2006; Bibollet-Ruche
et al., 2004). SIVcpz infection infects up to 35% of wild-liv-
ing chimpanzees but is unevenly distributed among wild
populations and is much less transmissible than ‘‘regular’’
SIV infections (Sharp et al., 2005; Keele et al., 2006).
Finally, SIVgsn/mus/mon and SIVcpz strains are quite
unusual in that they encode a vpu gene, which is absent
from other primate lentiviruses. Vpu itself does not down-
regulate TCR-CD3. However, there may be other (as yet
unidentified) Vpu functions that may diminish the selective
advantage of maintaining Nef-mediated TCR-CD3 down-
modulation. This would explain the apparently coinciden-
tal loss of Nef function in two distinct lineages, both of
which encode a vpu gene.
Nef-Mediated Inhibition of T Cell Activation
Attenuates Even Pathogenic SIVmac Infection
A protective role of Nef-mediated TCR-CD3 downmodula-
tion is consistent with the nonpathogenic phenotype of
naturally occurring SIV infections; however, two models
of experimental SIV infection appear to be at odds with
this hypothesis. First, SIVmac (a virus inadvertently trans-
mitted from naturally infected SMs to macaques in captiv-
ity; Daniel et al., 1985) causes immunodeficiency and AIDS
in macaques (Kestler et al., 1991) despite the fact that its
Nef protein efficiently downmodulates TCR-CD3. Second,
SIVmac viruses containing HIV-1 nef genes (the so-called
Nef-SHIVs) do not exert greater pathogenicity than wild-
type SIVmac239 in experimentally infected macaques (Al-
exander et al., 1999; Kirchhoff et al., 1999). The Nef-SHIV
chimeras are highly artificial viruses that express Nef
from a different genomic location and at markedly reduced
levels and are thus not really informative as to the role
of TCR-CD3 downregulation in natural SIV infection. The
in vivo phenotype of SIVmac is somewhat more difficult to
explain, since the SIVmac Nef downmodulates TCR-CD3
not only in infected human but also in macaque PBMCs
(unpublished data). SIVmac-infected macaques develop
immunodeficiency and AIDS, indicating that even efficient
Nef-mediated downmodulation of TCR-CD3 is not suffi-
cient to prevent immunodeficiency and disease. However,1064 Cell 125, 1055–1067, June 16, 2006 ª2006 Elsevier Inc.SIVmac is not pathogenic when introduced back into SMs
by experimental infection (Kaur et al., 1998). Thus, the
pathogenic phenotype of SIVmac in macaques seems to
be more a function of the host species than an inherent viral
phenotype. Moreover, changes in SIVmac Nef that in-
crease T cell activation also enhance its virulence (Du
et al., 1995), whereas changes that selectively retain the
TCR-CD3 downmodulation (but abrogate other Nef func-
tions) result in an even more attenuated in vivo phenotype
than an SIVmac strain that is lacking nef entirely (Mu¨nch
et al., 2002). Thus, even in the pathogenic SIVmac/ma-
caque model, the ability of Nef to inhibit T cell activation
has a mitigating effect on viral virulence.
Conclusions
In summary, our data indicate that Nef-mediated down-
modulation of TCR-CD3 is an evolutionarily highly con-
served function of primate lentiviruses and a potential
contributor to their nonpathogenic phenotype in most
natural hosts. Thus, SIV Nef not only facilitates SIV persis-
tence by downmodulation of CD4 and MHC-I but may also
act as a ‘‘rheostat,’’ allowing high enough levels of T cell
activation to ensure sufficient viral replication and trans-
mission, while at the same time preventing escalation of
immune activation to levels that may be harmful to the
host. Interestingly, this function was lost during primate
lentiviral evolution in a subset of SIVs, including SIVcpz,
the immediate precursor of HIV-1. While the presence of
a vpu gene and other changes may have compensated
for (and even precipitated) this loss of Nef function in the
chimpanzee hosts, the inability to reduce T cell activation
may have predisposed the simian precursor of HIV-1 to
greater virulence upon transmission to humans. The fact
that a second SIV (SIVsmm) with an intact TCR-CD3
downmodulation function resulted in an overall less path-
ogenic human (HIV-2) infection is consistent with this hy-
pothesis (Marlink et al., 1988; Michel et al., 2000; Pepin
et al., 1991). The present report provides the framework
for future investigations aimed at exploring directly the
contribution of Nef-mediated TCR-CD3 downmodulation
to primate lentiviral pathogenesis (or lack thereof) in ap-
propriate animal models.
EXPERIMENTAL PROCEDURES
Proviral Constructs
Generation of HIV-1 (NL4-3-based) proviral constructs carrying func-
tional nef genes followed by an IRES and the eGFP gene has been de-
scribed (Schindler et al., 2003, 2005). Splice overlap extension PCR
was used to replace the HIV-1 NL4-3 nef allele with the nef genes listed
in Table S1. The proviral HIV-1 constructs are replication competent
and express all viral genes, including nef, via the regular LTR promoter
and splice sites. The integrity of all PCR-derived inserts was confirmed
by sequence analysis. nef-defective control constructs contained
a premature stop codon at position 40 of the HIV-1 NL4-3 nef (nef*),
or this same stop codon combined with a second stop codon at posi-
tion 3 and a mutation of the initiation codon (nef). Similar approaches
were used to generate replication-competent SIVmac (strain 239) and
SIVagm (strain TAN1) based IRES/eGFP constructs.
Amplification of SIVsmm nef Alleles from Plasma of Infected
SMs
Blood samples were obtained from 19 naturally SIVsmm-infected SMs
housed at the Yerkes National Primate Research Center of Emory Uni-
versity and maintained in accordance with NIH guidelines. Plasma viral
RNA was extracted using the QIAamp Viral RNA Kit (QIAGEN), and nef
genes were amplified by RT-PCR using primers SM-Nef-F1 (50-GACA
GATAGAATATATTCATTTCC-30) and SM-Nef-R1 (50-TCTGCCAGCCT
CTCCGCAGAG-30). For expression in Jurkat T cells, nef genes were
PCR amplified using primers containing the XbaI and MluI restriction
sites and cloned in bulk into a bicistronic expression vector (Greenberg
et al., 1998). Sequence analysis of two clones per amplicon (two per
animal) confirmed the integrity of these nef alleles. Transfection of Ju-
rkat T cells and flow cytometric analyses were performed as described
(Mu¨nch et al., 2005).
Cell Culture and Transfection
Jurkat and 293T cells were cultured as described (Mu¨nch et al., 2005;
Kirchhoff et al., 2004). PBMCs from healthy human donors were iso-
lated using lymphocyte separation medium (Biocoll Separating Solu-
tion, Biochrom), stimulated for 3 days with PHA (1 mg/ml), and cultured
in RPMI1640 medium with 10% FCS and 1 ng/ml IL-2 prior to infection.
SM PBMCs were isolated from 40 ml of anticoagulated peripheral
blood using two sequential Ficoll gradients (Pharmacia). CD8+ cells
and CD19+ cells were removed by antibody-coupled magnetic beads
(Miltenyi Biotec). Cells were stimulated with PHA (0.3 mg/ml) and in-
fected with HIV/SIV Nef/eGFP constructs 4 days following stimulation.
Virus Stocks and Transductions
To generate viral stocks, 293T cells were cotransfected with the HIV/
SIV Nef/eGFP constructs and a plasmid (pHIT-G) expressing the vesic-
ular stomatitis virus G protein (Schindler et al., 2003, 2005). The latter
was used to achieve high initial infection levels for functional analysis.
However, all HIV-1 constructs contained intact env genes and were
thus replication competent following the first round of infection. VSV-G
pseudotyping did not affect Nef-mediated surface-receptor modula-
tion. Virus stocks were quantified using a p24 antigen capture assay
provided by the NIH AIDS Research and Reference Reagent Program.
Flow Cytometric Analysis
CD4, TCR-CD3, MHC-I, CD28, and eGFP reporter expression in Jurkat
T cells or human PBMCs transduced with HIV-1 (NL4-3) constructs co-
expressing Nef and eGFP were measured as described (Schindler
et al., 2003; Kirchhoff et al., 2004). CD69 and IL-2R expression was
measured by standard FACS staining using CD69 (BD Pharmingen,
Clone FN50) and CD25 (BD Pharmingen, Clone M-A251) mAbs. Flow
cytometric analysis of SM PBMCs was performed on a LSRII (Becton
& Dickinson) using FACSAria software, using anti-CD3 (SP-34-2), anti-
CD4 (L200), anti-CD8 (RPA-T8), anti-CD25 (2A3), and anti-CD28
(CD28.2) antibodies (Becton & Dickinson). SM cells that stained posi-
tive for CD8 were excluded from the analysis. For quantification of
Nef-mediated modulation, the levels of receptor expression (red fluo-
rescence) were determined for cells expressing a specific range of
eGFP (Schindler et al., 2003; Kirchhoff et al., 2004). The extent of
downmodulation or induction (n-fold) was calculated by dividing the
MFI obtained for cells infected with the nef-minus NL4-3 control
viruses by the corresponding values obtained for cells infected with
viruses coexpressing nef and eGFP.
NFAT Induction
Jurkat cells stably transfected with an NFAT-dependent reporter gene
vector (Fortin et al., 2004) were either left uninfected or transduced
with HIV-1 Nef/eGFP constructs expressing various nef alleles. Except
for those cells used as controls, cultures were treated with PHA
(1 mg/ml; Murex), anti-CD3 AB (1 mg/ml; BD Pharmingen, Clone HIT3a),
or anti-CD3/CD28 beads (Trickett and Kwan, 2003) at a cell:bead ratio
of 1:1. Luciferase activity was measured and n-fold induction deter-mined by calculating the ratio between measured relative light units
of treated samples over untreated samples as described previously
(Fortin et al., 2004).
Induction of PBMC Activation and Apoptosis
Human PBMCs were first stimulated with PHA (1mg/ml) for 3 days. Sub-
sequently, the cells were cultured in RPMI1640 (10% FCS, 1 ng/ml
IL-2), infected with various HIV-1 eGFP/Nef constructs, and cultured
for another 2 days. At this time, the PBMCs expressed very low levels
of CD69 and IL-2R and hence had a resting phenotype. Thereafter,
the PBMCs were treated a second time with PHA, and CD69 and IL-
2R expression levels were measured by FACS analysis 1 and 4 days
later. The frequency of virally infected apoptotic cells was determined
using the Annexin V (AnV) Apoptosis Detection Kit (BD Bioscience) as
recommended by the manufacturer. To compare PHA- and FAS-in-
duced apoptosis, PBMCs were stimulated with 1 mg/ml PHA or treated
with 10 ml/ml CD95Ab (Apo-I hybridoma supernatant, kindly provided
by K.M. Debatin) at 2 days posttransduction. Subsequently, aliquots
of the cultures were treated with 20 mM zVAD-FMK (Sigma). CD95Ab-
induced cell death was measured 12 hr postinduction, whereas PHA-
induced apoptosis was determined 3 days poststimulation (dps) as
described (Schindler et al., 2005).
Phylogenetic Analyses
Sequences were aligned using CLUSTAL W (Thompson et al., 1994).
Sites with a gap in any sequence were discarded. Trees were made
by the Bayesian method implemented in MrBayes v3.0 (Huelsenbeck
and Ronquist, 2001) using 1 million or 10 million generations and
burn-in of 10%. Estimated sample sizes from Tracer (Rambaut and
Drummond, 2003) were above 100 for all trees.
Statistical Analysis
The activities of group 1 (n = 12) and group 2 (n = 18) nef alleles and of
nef alleles derived from SMs with low (n = 8) or high (n = 11) CD4+ T cell
counts were compared using a two-tailed Student’s t test. The PRISM
package version 4.0 (Abacus Concepts, Berkeley, CA, USA) was used
for all calculations.
Supplemental Data
Supplemental Data include three figures and one table and can be
found with this article online at http://www.cell.com/cgi/content/full/
125/6/1055/DC1/.
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